There is a shortage of injectable and oral GLP-1 analogue receptor agonist (GLP-1s) medicines for type 2 diabetes. These include Dulaglutide (Trulicity®), Exenatide (Byetta® or Bydureon®), Semaglutide (Ozempic® or Rybelsus®), Liraglutide (Victoza®) and Lixisenatide (Lyxumia®).
Due to increased use, manufacturers are currently unable to produce enough of these medicines to meet demand. Supply is not expected to return to normal until at least the middle of 2024.
In line with national guidance, we are doing everything we can as quickly as possible to source availability of these medications in local community pharmacies and to address medication options.
Please continue to take medication as prescribed. Patients using GLP-1s for type 2 diabetes will be contacted in due course to arrange a medication review and a blood test if required.
GLP-1s should only be obtained on prescription from UK registered pharmacies.
What to do if I feel unwell
If you feel unwell with symptoms of high blood glucose e.g. feeling very thirsty, increased urination, feeling weak or tired, blurred vision or losing weight, please seek medical advice in the usual way.
Please call NHS 111 for help if you think you have high blood glucose and you are feeling sick, being sick or have stomach pain, you are breathing more quickly than usual or your heart is beating faster than usual, you feel drowsy or are struggling to stay awake, your breath has a fruity smell (like pear drop sweets), you feel confused or have difficulty concentrating, you have a high level of ketones.
For further information
As we learn more about the shortage and how long this may last, we will update this information page.
This useful leaflet from the local hospital trust provides further advice and information about the current supply issues.
